World Asthma Day 2026, May 5: “Access to anti-inflammatory inhalers for everyone with asthma – still an urgent need.” Image courtesy of the Global Initiative for Asthma (GINA).
World Asthma Day 2026 calls attention to the need that everyone with asthma can access anti-inflammatory inhalers and the healthier indoor environments needed for management.
The Importance of World Asthma Day 2026
World Asthma Day, observed annually on the first Tuesday in May, falls on May 5, 2026. The theme set by the Global Initiative for Asthma (GINA) is “Access to anti-inflammatory inhalers for everyone with asthma – still an urgent need.” It is a powerful reminder that despite decades of progress in asthma science, equitable access to essential medication remains out of reach for millions of people.
The Global Burden of Asthma
Asthma is one of the most common chronic non-communicable diseases, affecting more than 260 million people worldwide and causing over 450,000 deaths each year. The vast majority of these deaths are preventable. Asthma attacks involve obstruction of the airways, caused by muscle spasm, inflammation, and mucus, which reduces the body’s ability to take in life-sustaining oxygen. The consequences extend far beyond individual sufferers, affecting families, carers, healthcare systems, and economies.
Why Inhaled Corticosteroids Are Essential
GINA emphasizes that inhaled corticosteroids (ICS) are essential for treating and controlling asthma. While short-acting bronchodilator relievers (such as salbutamol, albuterol, and terbutaline) provide temporary relief by relaxing airway muscles, they do not address the underlying inflammation that drives asthma. Inhaled corticosteroids treat that inflammation, preventing attacks and reducing the risk of hospitalization and death. GINA recommends that most people with asthma, including most pre-school children, receive an ICS-containing inhaler, ideally as a combination 2-in-1 inhaler that delivers both an inhaled corticosteroid and a quick-acting reliever in a single device.
A Stark Inequity in Access
In low- and middle-income countries, lack of availability and high cost of inhaled corticosteroid-containing inhalers contribute to the fact that 96% of global asthma deaths occur in these regions. Even in high-income countries, financial barriers prevent many people from accessing the inhalers they need, leading to poorly controlled asthma and preventable deaths. GINA is calling on policymakers, governments, payers, and pharmaceutical manufacturers to ensure that inhaled corticosteroids are affordable and available to everyone with asthma.
Creating Healthier Indoor Environments
At Allergy Standards, our work focuses on the environmental side of asthma and allergy management. The Asthma & Allergy Friendly® Certification Program, run in collaboration with the Asthma and Allergy Foundation of America (AAFA), addresses the indoor environment where people spend the majority of their time. Common triggers such as dust mite allergen, pet dander, mold, and volatile organic compounds (VOCs) can aggravate symptoms and undermine even the best medication regimens.
The Asthma & Allergy Friendly® Certification Program tests and certifies products that meet strict, scientifically based standards for reducing exposure to triggers. From air cleaners and vacuums to paints, flooring, and bedding, certification gives consumers, healthcare professionals, and procurement teams a credible way to identify products that genuinely support asthma and allergy management. Reducing the indoor trigger burden complements pharmacological treatment and can meaningfully improve quality of life for people with asthma.
A Call for Action
This World Asthma Day, the message is clear. Improving outcomes for people with asthma requires action on multiple fronts: ensuring affordable access to inhaled corticosteroids, supporting patient education and self-management, and reducing exposure to environmental triggers in homes, schools, and workplaces. Policymakers, healthcare providers, manufacturers, and individuals all have a part to play.
By combining equitable access to anti-inflammatory inhalers with healthier indoor environments, we can move closer to a world where no one dies from preventable asthma, and where every person with asthma can live a full and active life.
Key Words
World Asthma Day 2026, Asthma, GINA, Inhaled Corticosteroids, Indoor Air Quality, AAFA, Asthma & Allergy Friendly® Certification, Global Health
Related Internal Links